AI and the Pharmaceutical Industry — Weekly 2026-W45
This page is a mechanical aggregation of the daily data and carries no commentary. See the daily pages for interpretation.
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
🧬 Drug Discovery1
- S2 Deal / PartnershipVariational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery — BioSpace11/03 11:46 JSTMerck
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance6
- S4 Amount disclosed[Tempus AI Q3 2026 Earnings Call] Tempus AI Turns First Profit as Revenue Jumps 23% to $411.5M; Raises Full-Year Guidance to $1.60B-$1.605Bplanned $1.605B — BigGo Finance11/02 23:54 JSTTempus AIAlso reported by 1: grafa.com
- S4 Amount disclosednPhase Secures $30 Million in Series D Funding to Drive Global Expansion of AI-Native Clinical Data Platform for Life Sciences$30 Million — FinancialContent11/02 21:07 JST
- S4 Amount disclosedCathie Wood's Ark Invest Buys $12M in Tempus AI Stock Amid Bullish Wall Street Calls$12M — CoinCodex11/02 21:58 JSTTempus AI
- S3 Capital moveTempus AI Q3 revenue slightly beats estimates; raises guidance — TradingView11/02 21:09 JSTTempus AI
- S3 Capital moveTempus AI Soars 10% on Q3 Beat and Raised Guidance as Oncology Sees “Accelerating Unit Growth” — TIKR.com11/03 02:04 JSTTempus AI
- S2 Deal / PartnershipTempus AI shares rise more than 10% on first adjusted profit and expanded partnerships — Traders Union11/03 04:28 JSTTempus AI